Old Web
English
Sign In
Acemap
>
Paper
>
Sa1874 INFLIXIMAB DE-ESCALATION IN PATIENTS WITH CROHN'S DISEASE IN CLINICAL REMISSION IS SAFE AND WELL TOLERATED
Sa1874 INFLIXIMAB DE-ESCALATION IN PATIENTS WITH CROHN'S DISEASE IN CLINICAL REMISSION IS SAFE AND WELL TOLERATED
2020
Jessica R. Allegretti
Emma L. McClure
Jenna Marcus
Beth-Ann Norton
Matthew J. Hamilton
Rachel W. Winter
Punyanganie S. de Silva
Sonia Friedman
Joshua R. Korzenik
Keywords:
De-escalation
Internal medicine
General surgery
Crohn's disease
Medicine
Infliximab
Diabetes mellitus
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
8
References
0
Citations
NaN
KQI
[]